Ruxolitinib, an oral JAK1 and JAK2 inhibitor, in...

Ruxolitinib, an oral JAK1 and JAK2 inhibitor, in myelofibrosis

Vaddi, Kris, Sarlis, Nicholas J, Gupta, Vikas
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
Expert Opinion on Pharmacotherapy
DOI:
10.1517/14656566.2012.732998
Date:
November, 2012
File:
PDF, 545 KB
english, 2012
Conversion to is in progress
Conversion to is failed